The Globe and Mail reports in its Tuesday edition that Organigram Holdings' shares surged up to 30 per cent Monday after the company announced a $124-million investment from a British tobacco giant, which it will use in part to create a new strategic innovation fund. The Globe's Irene Galea writes that BT DE Investments Inc., a subsidiary of British American Tobacco (BAT), will be issued 38 million shares at a price of $3.22 per share in three tranches, about double the $1.59 that shares were trading at the end of the previous close on Friday. The investment brings BAT's common voting share ownership to 30 per cent and overall equity interest to 45 per cent (including preferred shares), the company said in a press release Monday morning. BAT has made a number of investments in Organigram since 2021, when it acquired 20 per cent of the company's equity. Of the total investment, Organigram will use $83-million to create "Jupiter," a fund designed to expand its geographic footprint outside of Canada. Organigram wants to take advantage of markets globally, where many cannabis companies are undervalued. The company is focused on advancing its non-combustible products, which include edibles, beverages and vapes.